Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2

Conditions

Myelodysplastic Syndromes 91Leukemia, Myeloid, Acute 77Precursor Cell Lymphoblastic Leukemia-Lymphoma 63Leukemia 49Lymphoma, Non-Hodgkin 45Lymphoma 41Leukemia, Lymphocytic, Chronic, B-Cell 41Hodgkin Disease 39Myeloproliferative Disorders 32Multiple Myeloma 30Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30Leukemia, Myelomonocytic, Chronic 23Leukemia, Myeloid, Accelerated Phase 23Leukemia, Myeloid, Chronic-Phase 22Burkitt Lymphoma 22Lymphoma, Mantle-Cell 21Lymphoma, B-Cell, Marginal Zone 21Congenital Abnormalities 21Lymphoma, Follicular 20Primary Myelofibrosis 19Lymphoma, Large B-Cell, Diffuse 19Neoplasms, Plasma Cell 18Lymphoma, Large-Cell, Immunoblastic 18Graft vs Host Disease 18Myelodysplastic-Myeloproliferative Diseases 17Blast Crisis 17Anemia, Refractory, with Excess of Blasts 17Dendritic Cell Sarcoma, Interdigitating 15Leukemia, Myelomonocytic, Juvenile 14Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 14

Interventions

fludarabine phosphate 5fludarabine 5Cyclophosphamide 5Whole-Body Irradiation 4Busulfan 3Antilymphocyte Serum 3Thiotepa 2Mycophenolic Acid 2Melphalan 2Alemtuzumab 2Therapeutics 1Tacrolimus 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Erythrocyte Transfusion 1Cyclosporins 1Clofarabine 1Bone Marrow Transplantation 1Blood Transfusion 1Blood Component Transfusion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bone Marrow Failure Disorders × Melphalan × Myeloid × Clear all
NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Neutropenia, Severe Congenital, Autosomal Recessive 3, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Primary Immunodeficiency Diseases, Acquired Immunodeficiency Syndrome, Anemia, Aplastic, Anemia, Sickle Cell, Hemoglobinopathies, Histiocytosis, Langerhans-Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Anemia, Diamond-Blackfan, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Macrophage Activation Syndrome

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡